MRNY

YieldMax MRNA Option Income Strategy ETF

$33.29

-0.18 (-0.54%)

AUM $140.13M

Expense Ratio 1.00%

NAV $35.66

Holdings 7

Asset Class Alternatives

Inception 10/23/2023

Provider YieldMax

Top Holdings

1 912797RF6 United States Treasury Bill 07/09/2026 18.84% 2 912797QX8 United States Treasury Bill 06/11/2026 17.30% 3 912797RG4 United States Treasury Bill 08/06/2026 15.41% 4 MRNA 260717C00050000 MRNA US 07/17/26 C50 14.23% 5 912797TR8 United States Treasury Bill 05/12/2026 8.45% 6 912797RS8 United States Treasury Bill 09/03/2026 8.35% 7 2MRNA 260717P00050010 MRNA 07/17/2026 50.01 P 7.69% 8 2MRNA 260515P00050010 MRNA 05/15/2026 50.01 P 6.68% 9 MRNA 260508C00046000 MRNA US 05/08/26 C46 3.93% 10 MRNA 260515C00053000 MRNA US 05/15/26 C53 2.82%

Fund Description

This actively managed exchange-traded fund, known as the YieldMax MRNA Option Income Strategy ETF (MRNY), is engineered to deliver consistent weekly income. It achieves this by strategically issuing call options or initiating call spreads that are tied to shares of MRNA. The fundamental design of this approach is to collect premiums from these options, while also providing investors with a means to participate in any upward movement in MRNA's stock valuation.